Additional file 6: Table S1. of SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer
2016
Internal codes for each case and the state of EGFR and SHP2 expression for each tumor. The first 12 cases were reanalyses of samples from a previous publication [14] in which the indicated samples were reported as triple-negative. Cases 84â 127 are new BTBC samples. Yellow highlighting represents the co-overexpression of SHP2 and EGFR, cyan blue represents SHP2-positive tumors that do not have EGFR overexpression, and gray represents EGFR-positive tumors without SHP2 overexpression. (DOC 66 kb)
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI